Experts warn of rising blood cancer cases among children, cite pollution and chemicals as key causes
BHUBANESWAR: The incidence of blood cancer or leukaemia in the country is on the upward spiral with a high number of children getting afflicted by the disease, experts said.
Addressing an event organised at IMS and SUM Hospital here to mark the World Blood Cancer Day on Wednesday, head of the Hematology department, Hemato Oncology, Bone Marrow Transplant Prof Priyanka Samal said pollution, radiation and use of chemical fertiliser are among the prime causes of blood cancer. 'Though new cases of leukemia are being detected among the young children in the age group of one to 10 years, around 80 to 90 pc of the children are able to defeat the disease with proper treatment and care,' she added.
The symptoms of the disease which include continued fever, fall in haemoglobin, total leukocyte count and platelet level, appearance of black spots on the body and bleeding, should not be ignored. 'Once diagnosed, it can be cured depending on the stage. We have the latest treatment regimen like bone marrow transplantation, haplo transplant and Chimeric Antigen Receptor- T (CAR-T) Cell Therapy, which have been very successful,' Dr Samal added.
Eminent neurosurgeon and SOA's principal advisor (health sciences) Prof Ashok Kumar Mahapatra, dean Prof Sanghamitra Mishra, medical superintendent (MS) Prof Pusparaj Samantasinghar and MS of SUM's Phulnakhara campus Prof Rajesh Lenka spoke.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
4 days ago
- Time of India
MGM successfully treats blood cancer patient with CAR T-Cell therapy
Indore: MGM Medical College on Saturday announced its successful treatment of a blood cancer patient using CAR T-cell therapy, making it the first govt medical institution in the state to do so. Tired of too many ads? go ad free now "The groundbreaking treatment was carried out under the supervision of department of clinical haematology, transfusion medicine, and bone marrow transplant," MGMMC dean Dr Arvind Ghanghoria said. He added that the patient, whose treatment began on Jan 26 this year at the Super Speciality Hospital, was successfully discharged on Saturday, four months after the therapy. Explained the CAR T-cell therapy process, Dr Ghanghoria said, "The patient undergoes an apheresis procedure to remove white blood cells. A normal patient's blood contains two types of white blood cells, B and T cells. T cells are separated from the white blood cells and then genetically modified using viral vectors. These genetically modified CAR T-cells are then re-infused into the patient. The Chimeric Antigen Receptor identifies specific proteins on the surface of cancer cells and destroys them. In this way, CAR T-cells eliminate cancer from the patient's body, leading to a cancer-free life," he said. Head of clinical haematology department Dr Akshay Lahoti highlighted that similar CAR T-cell therapy treatments abroad can cost up to Rs 4 crore. He extended gratitude for the extensive support received from various individuals and organisations, including Dr Rahul Bhargava (head haematologist, Fortis Hospital), Dr Sudhir Kataria, Dr Preeti Malpani, Dr Prachi Chaudhary, Dr Ashok Yadav, Dr Sumit Shukla, and others. Tired of too many ads? go ad free now Indore: MGM Medical College on Saturday announced its successful treatment of a blood cancer patient using CAR T-cell therapy, making it the first govt medical institution in the state to do so. "The groundbreaking treatment was carried out under the supervision of department of clinical haematology, transfusion medicine, and bone marrow transplant," MGMMC dean Dr Arvind Ghanghoria said. He added that the patient, whose treatment began on Jan 26 this year at the Super Speciality Hospital, was successfully discharged on Saturday, four months after the therapy. Explained the CAR T-cell therapy process, Dr Ghanghoria said, "The patient undergoes an apheresis procedure to remove white blood cells. A normal patient's blood contains two types of white blood cells, B and T cells. T cells are separated from the white blood cells and then genetically modified using viral vectors. These genetically modified CAR T-cells are then re-infused into the patient. The Chimeric Antigen Receptor identifies specific proteins on the surface of cancer cells and destroys them. In this way, CAR T-cells eliminate cancer from the patient's body, leading to a cancer-free life," he said. Head of clinical haematology department Dr Akshay Lahoti highlighted that similar CAR T-cell therapy treatments abroad can cost up to Rs 4 crore. He extended gratitude for the extensive support received from various individuals and organisations, including Dr Rahul Bhargava (head haematologist, Fortis Hospital), Dr Sudhir Kataria, Dr Preeti Malpani, Dr Prachi Chaudhary, Dr Ashok Yadav, Dr Sumit Shukla, and others.
New Indian Express
5 days ago
- New Indian Express
Experts warn of rising blood cancer cases among children, cite pollution and chemicals as key causes
BHUBANESWAR: The incidence of blood cancer or leukaemia in the country is on the upward spiral with a high number of children getting afflicted by the disease, experts said. Addressing an event organised at IMS and SUM Hospital here to mark the World Blood Cancer Day on Wednesday, head of the Hematology department, Hemato Oncology, Bone Marrow Transplant Prof Priyanka Samal said pollution, radiation and use of chemical fertiliser are among the prime causes of blood cancer. 'Though new cases of leukemia are being detected among the young children in the age group of one to 10 years, around 80 to 90 pc of the children are able to defeat the disease with proper treatment and care,' she added. The symptoms of the disease which include continued fever, fall in haemoglobin, total leukocyte count and platelet level, appearance of black spots on the body and bleeding, should not be ignored. 'Once diagnosed, it can be cured depending on the stage. We have the latest treatment regimen like bone marrow transplantation, haplo transplant and Chimeric Antigen Receptor- T (CAR-T) Cell Therapy, which have been very successful,' Dr Samal added. Eminent neurosurgeon and SOA's principal advisor (health sciences) Prof Ashok Kumar Mahapatra, dean Prof Sanghamitra Mishra, medical superintendent (MS) Prof Pusparaj Samantasinghar and MS of SUM's Phulnakhara campus Prof Rajesh Lenka spoke.
Time of India
6 days ago
- Time of India
Children battle leukaemia better: Cancer experts
1 2 Bhubaneswar: Children in the age group of one to 10 years are getting leukaemia, but they are displaying the capacity to defeat the ailment better, said experts attending a programme organised at IMS and SUM Hospital here to mark World Blood Cancer Day on Wednesday. Dr Priyanka Samal, professor and head of department of haematology, hemato oncology, bone marrow transplant and cellular therapy at IMS and SUM Hospital here, said the incidence of blood cancer or leukaemia in India is on the upswing, with a high number of children affected. "Though new cases of leukaemia are being detected among the young, around 80 to 90 per cent children are able to defeat the disease with proper treatment and care," said Samal. She said pollution, radiation, and the use of chemical fertiliser were among the prime causes of the disease. The symptoms of the disease, which include continued fever, a fall in haemoglobin, total leukocyte count and platelet levels, appearance of black spots on the body, and bleeding, should not be ignored. This calls for urgent blood examination of the patient and medical consultation, she added. "In case children suffer from fever for 8 to 10 days, they should get medical attention," said Samal.
